Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Calpain inhibitor MDL28170 improves the transplantation-mediated therapeutic effect of bone marrow-derived mesenchymal stem cells following traumatic brain injury

Fig. 5

Lesion volume assessment of TBI brain sections stained with Cresyl violet 7 days after treatment or cell transplantation. a Sham group, no injury. b TBI with vehicle (20% DMSO, v/v). c TBI with MDL28170 treatment. d TBI with BMSC transplantation. e TBI with MDL28170 pretreatment then BMSC transplantation. f Quantification of lesion volume in each group (n = 3 for the sham group, n = 5 for all other groups). *P < 0.05, **P < 0.01 by one-way ANOVA followed by Turkey post-tests. Scale bars, 2 mm (a–e). TBI, traumatic brain injury; BMSCs, bone marrow mesenchymal stem cells

Back to article page